Last edition
News about Global Pharma
African Air Cargo Aims for Long-Term Expansion
Africa’s air cargo market is setting its sights on long-term growth, but in the meantime the continent continues to suffer from the strength of the US dollar and the impact of inflation on export markets.
Global Pharma | 09/05/2023 | By Manvi | 587
Nexus Pharmaceuticals specialises in sterile injectable medications and is aware of the rising patient need for affordable, high-quality generic injections.
Global Pharma | 09/05/2023 | By Manvi | 607
Lupin acquires French Pharma Co Medisol
With this acquisition, Lupin will gain access to Medisol’s portfolio of seven injectable products across four therapeutic areas, including pain management, anti-inflammatory, cardiovascular diseases, and obstetrics
Global Pharma | 09/05/2023 | By Sudeep Soparkar | 716
South Korea-based Daewoong Pharma to invest $74.6 M to produce botulinum toxin product Nabota
The facility is set to be built in Hwaseong, Gyeonggi Province
Global Pharma | 09/05/2023 | By Sudeep Soparkar | 1743
Mettler-Toledo Product Inspection is showcasing a wide range of stand-alone and fully-integrated automated smart product inspection systems at Interpack 2023.
Global Pharma | 04/05/2023 | By Manvi | 792
CPHI Announces to Open CPHI & PMEC at Shanghai Expo Center in June
CPHI & PMEC China will open in June (19-21st) at the Shanghai New International Expo Center as international audiences return in search of regional ingredient suppliers.
Global Pharma | 04/05/2023 | By Manvi | 803
Astellas Pharma buys Iveric Bio for $5.9 Bn
The deal marks the fifth major overseas acquisition by Astellas
Global Pharma | 02/05/2023 | By Sudeep Soparkar | 1241
IPCA Labs to acquire 33.4 per cent stake in Unichem Laboratories for Rs 1,034 Cr
Ipca Laboratories has agreed to acquire the stake in Unichem Laboratories, amounting to 2,35,01,440 fully paid-up equity shares at Rs 440 per equity share
Global Pharma | 25/04/2023 | By Sudeep Soparkar | 826
Global Pharma | 24/04/2023 | By Sudeep Soparkar | 1614
The newly acquired facility is a cGMP manufacturing plant that produces a wide variety of high-quality sterile injectable drug products.
Global Pharma | 07/04/2023 | By Manvi | 699
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy